Suchergebnisse - "Sebastian, Shaji"

PubPharm (192)

21

Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease

enthalten in: Biomolecules | 2023

von Hanić, M. | Vučković, F. | Deriš, H. | +108

22

Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2023

von Ellul, P. | Schembri, J. | Vella Baldacchino, A. | +25

ErratumIn: J Crohns Colitis. 2023 Mar 09;:. - PMID 36896740

23

Development of a core descriptor set for Crohn's anal fistula

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2023

von ENiGMA CODE collaborators | Williams, K. | Lamidi, S. | +97

24

ECCO Topical Review : Roadmap to Optimal Peri-Operative Care in IBD

enthalten in: Journal of Crohn's & colitis | 2023

von Sebastian, S. | Segal, J. | Hedin, C. | +12

25

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD) : an analysis of a prospective multicentre cohort study

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Liu, Z. | Le, K. | Zhou, X. | +120

CommentIn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):99-100. - PMID 36481042

26

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

enthalten in: Gut | 2023

von Kennedy, N. | Janjua, M. | Chanchlani, N. | +20

27

Coronavirus disease - 19 immunity in inflammatory bowel disease patients : The progressive discovery from ignorance

enthalten in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology | 2023

von Sebastian, S.

CommentOn: Indian J Gastroenterol. 2023 Feb;42(1):64-69. - PMID 36598745

28

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

enthalten in: Gastroenterology | 2023

von Liu, Z. | Alexander, J. | Lin, K. | +70

29

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

enthalten in: EBioMedicine | 2023

von Alexander, J. | Mullish, B. | Danckert, N. | +24

30

Coronavirus disease - 19 immunity in inflammatory bowel disease patients: The progressive discovery from ignorance

enthalten in: Indian Journal of Gastroenterology | 2023

von Sebastian, S.